Identifying disease-associated signaling pathways through a novel effector gene analysis

Area of Science:

• Bioinformatics
• Computational Biology
• Systems Biology

Background:

• Signaling pathway analysis is crucial for understanding disease cell biology.
• Effector genes determine cell behavior based on received signals, which differ between normal and disease states.
• Current methods often overlook these signal variations.

Purpose of the Study:

• To develop a novel method, Signaling Pathway Functional Attributes analysis (SPFA), for analyzing signal variations.
• To assess the effectiveness of SPFA in identifying differences in effector gene signaling between normal and disease conditions.

Main Methods:

• Developed the Signaling Pathway Functional Attributes analysis (SPFA) method.
• SPFA analyzes signal variations in effector genes across different signaling pathways between normal and disease states.
• Compared SPFA against seven other methods using 33 Gene Expression Omnibus datasets.

Main Results:

• SPFA ranked first in median rank of target pathways and fourth in median p-value across datasets.
• SPFA demonstrated a modest percentage of significant pathways, suggesting balanced false positive and negative rates.
• The method effectively identified abnormal functional attributes and pathway components.

Conclusions:

• The SPFA method provides a valuable approach to analyzing signal variations in biological pathways.
• SPFA's performance is comparable to existing methods, with potential for identifying disease-specific functional attributes.
• The SPFA R code is publicly available for broader research application.